Zhang X - Search Results

1

Profound Perturbation in the Metabolome of a Canine Obesity and Metabolic Disorder Model.

Qu W, Chen Z, Hu X, Zou T, Huang Y, Zhang Y, Hu Y, Tian S, Wan J, Liao R, Bai L, Xue J, Ding Y, Hu M, Zhang XJ, Zhang X, Zhao J, Cheng X, She ZG, Li H. Qu W, et al. Among authors: zhang xj, zhang x, zhang y. Front Endocrinol (Lausanne). 2022 Apr 19;13:849060. doi: 10.3389/fendo.2022.849060. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35620391 Free PMC article.

2

The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Zhang XJ, Jiang DS, Li H. Zhang XJ, et al. Br J Pharmacol. 2015 Dec;172(23):5457-76. doi: 10.1111/bph.12881. Epub 2015 Feb 27. Br J Pharmacol. 2015. PMID: 25131895 Free PMC article. Review.

3

Interferon regulatory factor 7 protects against vascular smooth muscle cell proliferation and neointima formation.

Huang L, Zhang SM, Zhang P, Zhang XJ, Zhu LH, Chen K, Gao L, Zhang Y, Kong XJ, Tian S, Zhang XD, Li H. Huang L, et al. J Am Heart Assoc. 2014 Oct 10;3(5):e001309. doi: 10.1161/JAHA.114.001309. J Am Heart Assoc. 2014. PMID: 25304854 Free PMC article.

4

Reply to: "Interferon regulatory factor 9 plays a dual function in health and disease".

Zhang XJ, Wang PX, Zhang P, Li H. Zhang XJ, et al. J Hepatol. 2015 Jun;62(6):1447-8. doi: 10.1016/j.jhep.2015.02.013. Epub 2015 Feb 14. J Hepatol. 2015. PMID: 25687426 Free article. No abstract available.

5

Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.

Zhu LH, Huang L, Zhang X, Zhang P, Zhang SM, Guan H, Zhang Y, Zhu XY, Tian S, Deng K, Li H. Zhu LH, et al. Among authors: zhang sm, zhang p, zhang x, zhang y. Clin Sci (Lond). 2015 Jul;129(2):129-45. doi: 10.1042/CS20140679. Clin Sci (Lond). 2015. PMID: 25751394

6

Interferon regulatory factor signalings in cardiometabolic diseases.

Zhang XJ, Zhang P, Li H. Zhang XJ, et al. Hypertension. 2015 Aug;66(2):222-47. doi: 10.1161/HYPERTENSIONAHA.115.04898. Epub 2015 Jun 15. Hypertension. 2015. PMID: 26077571 Review. No abstract available.

7

Targeting Interferon Regulatory Factor for Cardiometabolic Diseases: Opportunities and Challenges.

Zhang Y, Zhang XJ, Li H. Zhang Y, et al. Curr Drug Targets. 2017;18(15):1754-1778. doi: 10.2174/1389450116666150804110412. Curr Drug Targets. 2017. PMID: 26240052 Review.

8

Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.

Hu J, Zhu XH, Zhang XJ, Wang PX, Zhang R, Zhang P, Zhao GN, Gao L, Zhang XF, Tian S, Li H. Hu J, et al. J Hepatol. 2016 Jan;64(1):146-59. doi: 10.1016/j.jhep.2015.08.021. Epub 2015 Aug 31. J Hepatol. 2016. PMID: 26334576

9

Liver capsule: IRFs in hepatocytes: Pathophysiology.

Wang PX, Zhang XJ, Li H. Wang PX, et al. Hepatology. 2016 May;63(5):1706. doi: 10.1002/hep.28433. Epub 2016 Feb 24. Hepatology. 2016. PMID: 26710247 No abstract available.

10

Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.

Xiang M, Wang PX, Wang AB, Zhang XJ, Zhang Y, Zhang P, Mei FH, Chen MH, Li H. Xiang M, et al. J Hepatol. 2016 Jun;64(6):1365-77. doi: 10.1016/j.jhep.2016.02.002. Epub 2016 Feb 6. J Hepatol. 2016. PMID: 26860405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182,484 results

Search Page

Filters